Vice President, Global Program Leader; GPL - Oncology, Solid Tumors

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Are you looking for a patient-focused, innovation-driven company that will inspire you and empower you to shine? Join us as a Vice President, Global Program Leader - Oncology, Solid Tumors in our Cambridge office.

At Takeda, we are transforming the pharmaceutical industry through our R&D-driven market leadership and being a values-led company. To do this, we empower our people to realize their potential through life-changing work. Certified as a Global Top Employer, we offer stimulating careers, encourage innovation, and strive for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our global teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to people around the world.

Here, you will be a vital contributor to our inspiring, bold mission.

OBJECTIVES:

The Global Program Leader is a seasoned leader fully dedicated, responsible and accountable for overarching Global Program(s). The GPL defines the asset strategy and leads all development and LCM projects associated with an asset from discovery to the marketplace. The guiding frame is defined by Takeda values of Patient-Trust-Reputation-Business.

• GPLs must be experienced, versatile and strong enterprise leaders
• Committed to simultaneously driving regulatory approval as well as launch and global patient access
• Ability to partner with all functions to drive, deliver and maximize asset value
• Effective in communicating, decision making and committing to areas of joint decision making

This is best achieved by a unique fit for purpose combination of skills reflected in these critical skill categories. Additional information in the Knowledge and Skills section.

• Inspirational Leadership
• Strategic Vision
• Strong Analytical Credibility
• Execution Skills
• Stakeholder Relationship

• For a given asset, responsible for an overarching global program strategy and execution. The GPL leads all research, development, commercial and LCM activities associated with an asset from discovery to the marketplace with full accountability. It may involve conventional molecules or novel modalities such as Cell Therapy or Gene Therapy, large scale programs through to launch and beyond, or smaller scale programs (e.g. rare disease or early development programs).
• Leads the Asset Strategy together with the commercial leader in the context of unmet medical need, competitive landscape, and key TPP attributes required to bring the product to market and to ensure global access for patients in context of Takeda’s values:
  Patient-Trust-Reputation-Business. This must take into consideration all development and commercial requirements as well as potential local/regional key requirements
• For a given asset, the GPL is the single leader of a cross functional team, the Global Program Team (GPT). The GPL ensures through the functional sub-teams leaders and their teams all project deliverables achieve defined project scope & objectives, budget and timelines with full functional support, keeping in mind value maximization and strong sense of the time/quality balance.
• Provides matrix management, strategic and tactical leadership to GPT members who are responsible for leading the key deliverables of the functional sub-teams for a given asset. GPT members are directly accountable to the GPL on the sub-team objectives.
• Accountable with the responsible Global Program Manager for activities operating budgets within the global program; leads budget setting in collaboration with functions and manages variance to budget ensuring overall Takeda financial objectives are met.
• Reports on program progress, issues, related updates, new requests for decision related to strategic scope or budget increase (new recommendations, change or buy-up) or timelines change and risks to TA Unit or and Takeda…